JPWO2021022173A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021022173A5
JPWO2021022173A5 JP2022506331A JP2022506331A JPWO2021022173A5 JP WO2021022173 A5 JPWO2021022173 A5 JP WO2021022173A5 JP 2022506331 A JP2022506331 A JP 2022506331A JP 2022506331 A JP2022506331 A JP 2022506331A JP WO2021022173 A5 JPWO2021022173 A5 JP WO2021022173A5
Authority
JP
Japan
Prior art keywords
lipid
lipids
immune cell
sterols
ionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543773A (ja
JP2022543773A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/044535 external-priority patent/WO2021022173A1/en
Publication of JP2022543773A publication Critical patent/JP2022543773A/ja
Publication of JPWO2021022173A5 publication Critical patent/JPWO2021022173A5/ja
Publication of JP2022543773A5 publication Critical patent/JP2022543773A5/ja
Pending legal-status Critical Current

Links

JP2022506331A 2019-07-31 2020-07-31 免疫細胞へのrna干渉剤の送達のための組成物及び方法 Pending JP2022543773A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962881279P 2019-07-31 2019-07-31
US62/881,279 2019-07-31
PCT/US2020/044535 WO2021022173A1 (en) 2019-07-31 2020-07-31 Compositions and methods for delivery of rna interference agents to immune cells

Publications (3)

Publication Number Publication Date
JP2022543773A JP2022543773A (ja) 2022-10-14
JPWO2021022173A5 true JPWO2021022173A5 (https=) 2023-08-08
JP2022543773A5 JP2022543773A5 (https=) 2023-08-08

Family

ID=72088399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506331A Pending JP2022543773A (ja) 2019-07-31 2020-07-31 免疫細胞へのrna干渉剤の送達のための組成物及び方法

Country Status (6)

Country Link
US (1) US20220280639A1 (https=)
EP (1) EP4003296A1 (https=)
JP (1) JP2022543773A (https=)
AU (1) AU2020319876A1 (https=)
CA (1) CA3149386A1 (https=)
WO (1) WO2021022173A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3852764A4 (en) * 2018-09-19 2022-06-15 ModernaTX, Inc. STEROL ANALOGUES AND USES THEREOF
CN113166783B (zh) 2018-10-09 2024-10-11 不列颠哥伦比亚大学 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法
CA3150061A1 (en) * 2019-08-07 2021-02-11 Modernatx, Inc. Compositions and methods for enhanced delivery of agents
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
IL303195A (en) 2020-11-25 2023-07-01 Akagera Medicines Inc Lipid nanoparticles for delivery of nucleic acids and related methods of use
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
MX2024002726A (es) 2021-09-03 2024-03-20 CureVac SE Nuevas nanoparticulas lipidicas para la administracion de acidos nucleicos.
WO2023064469A1 (en) * 2021-10-13 2023-04-20 Modernatx, Inc. Compositions of mrna-encoded il15 fusion proteins and methods of use thereof
WO2023073228A1 (en) 2021-10-29 2023-05-04 CureVac SE Improved circular rna for expressing therapeutic proteins
US20250099614A1 (en) 2022-01-28 2025-03-27 CureVac SE Nucleic acid encoded transcription factor inhibitors
WO2023148303A1 (de) * 2022-02-02 2023-08-10 Mslsolutions Gmbh Verfahren zur medikament- und impfstoffherstellung
WO2023227608A1 (en) 2022-05-25 2023-11-30 Glaxosmithkline Biologicals Sa Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide
EP4531819A2 (en) 2022-05-25 2025-04-09 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
CN115286674A (zh) * 2022-06-13 2022-11-04 湖北英纳氏生物科技有限公司 一种阳离子脂质体及其制备方法
EP4539831A2 (en) * 2022-06-17 2025-04-23 The University of Chicago Targeted nanomedicine for treating lung disorders
CN116589435A (zh) * 2022-06-20 2023-08-15 成都威斯津生物医药科技有限公司 用于核酸递送的可电离脂质及其组合物
WO2024026475A1 (en) * 2022-07-29 2024-02-01 Modernatx, Inc. Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
EP4590279A1 (en) * 2022-09-20 2025-07-30 Emory University Lipid nanoparticles comprising nucleic acids encoding therapeutic genes and uses in medical methods
WO2024089638A1 (en) 2022-10-28 2024-05-02 Glaxosmithkline Biologicals Sa Nucleic acid based vaccine
WO2024131810A1 (en) * 2022-12-21 2024-06-27 Suzhou Abogen Biosciences Co., Ltd. Lipid nanoparticles comprising sterol-modified phospholipids
EP4642434A2 (en) * 2022-12-29 2025-11-05 Life Technologies Corporation Lipid compositions on the basis of ionizable lipids, use for delivery to immune cells
CN116143707B (zh) * 2023-02-24 2024-04-19 山东大学 一种碱基可电离脂质及其制备方法与应用
KR20250153298A (ko) 2023-03-08 2025-10-24 큐어백 에스이 핵산 전달을 위한 신규의 지질 나노입자 제형
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
WO2025074292A2 (en) * 2023-10-06 2025-04-10 Pfizer Inc. Immunogenic compositions
WO2025186725A2 (en) * 2024-03-06 2025-09-12 Pfizer Inc. Improved lnp formulations and uses thereof

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
US20050222064A1 (en) 2002-02-20 2005-10-06 Sirna Therapeutics, Inc. Polycationic compositions for cellular delivery of polynucleotides
MX342785B (es) 2009-06-10 2016-10-12 Alnylam Pharmaceuticals Inc Formulacion mejorada de lipido.
CA2824526C (en) 2011-01-11 2020-07-07 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
US8691750B2 (en) * 2011-05-17 2014-04-08 Axolabs Gmbh Lipids and compositions for intracellular delivery of biologically active compounds
US10821175B2 (en) 2014-02-25 2020-11-03 Merck Sharp & Dohme Corp. Lipid nanoparticle vaccine adjuvants and antigen delivery systems
SMT202200502T1 (it) * 2014-06-25 2023-01-13 Acuitas Therapeutics Inc Nuovi lipidi e formulazioni di nanoparticelle lipidiche per l'erogazione di acidi nucleici
US20180000953A1 (en) * 2015-01-21 2018-01-04 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
IL307179A (en) 2015-10-28 2023-11-01 Acuitas Therapeutics Inc Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
HRP20220652T1 (hr) 2015-12-10 2022-06-24 Modernatx, Inc. Pripravci i postupci unosa terapijskih sredstava
JP2021512090A (ja) * 2018-01-30 2021-05-13 モデルナティーエックス, インコーポレイテッド 免疫細胞に薬剤を送達するための組成物及び方法
US20230081530A1 (en) * 2018-09-14 2023-03-16 Modernatx, Inc. Methods and compositions for treating cancer using mrna therapeutics

Similar Documents

Publication Publication Date Title
JPWO2021022173A5 (https=)
Inglut et al. Immunological and toxicological considerations for the design of liposomes
Scheeder et al. Molecular mechanisms of cationic fusogenic liposome interactions with bacterial envelopes
Chuffa et al. Melatonin-loaded nanocarriers: New horizons for therapeutic applications
Jackman et al. Rupture of lipid vesicles by a broad-spectrum antiviral peptide: influence of vesicle size
Fariya et al. Bolaamphiphiles: a pharmaceutical review
Atukorale et al. Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes
H. Ucisik et al. Emulsomes meet S-layer proteins: an emerging targeted drug delivery system
Wang et al. Isothermal self-assembly of spermidine–DNA nanostructure complex as a functional platform for cancer therapy
JP5226693B2 (ja) ミトコンドリア機能の改善のためのカルジオリピン含有リポソーム
Gupta et al. Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting
MX2010005089A (es) Nanoparticulas tipo micela autoensambles para el suministro sistemico de genes.
Samia et al. Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa
JP2009528340A5 (https=)
JP2014529328A5 (https=)
JP2017517533A5 (https=)
EP1245249A2 (fr) Utilisation d'un composé amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
Thanki et al. Improved oral bioavailability and gastrointestinal stability of amphotericin B through fatty acid conjugation approach
RU2006101394A (ru) Функционально реконструированные вирусные мембраны, содержащие адъювант
González-Cela-Casamayor et al. Novel osmoprotective DOPC-DMPC liposomes loaded with antihypertensive drugs as potential strategy for glaucoma treatment
CO2025018346A2 (es) Formulaciones y composiciones de nanopartículas lipídicas
Gomes et al. From Benznidazole to new drugs: Nanotechnology contribution in Chagas disease
Gaur et al. Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery
JPWO2020041783A5 (https=)
BR112022000925A2 (pt) Nanopartículas de rna multilamelares